Please assess the completion status of the following clinical trial:

Trial Title: PET/MRI Perfusion and CT Perfusion in Solid Tumors

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* indication as stated above~* written informed consent~* patients with suspected or confirmed solid malignant tumors of the neck, chest or abdomen who have an indication for a PET/CT~Exclusion Criteria:~* pregnant or breast feeding women~* non compliance of the patient to follow the study instructions (e.g. hearing problems, dementia)~* Inclusion in another clinical trial 30 days prior to inclusion~* age \< 30years~* contraindication for MRI (cardiac pacemaker, certain metal implants, claustrophobia~* known allergies to contrast CT or MRI contrast media~* patients with an glomerular filtration rate of \< 60ml/min/1.73m2

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).